Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms.
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
Avacta said that the deal will enable scientists to perform a laboratory test to detect the SARS-CoV-2 spike protein and some of its dominant variants.
The UK government said that everyone in England will be able to access free lateral flow testing for SARS-CoV-2 twice a week to support the reopening of society.
The test runs on DiaSorin's Liaison XL Analyzer and may be used by any lab CLIA-certified to perform moderate- or high-complexity tests, according to the FDA.